Apollo Health Ventures
Venture capital firm investing in seed and early stage biotechnology companies
Apollo Health Ventures is an Early Stage Investment Firm interested in accelerating breakthrough scientific discoveries to the clinic by building life science companies around new therapeutic technologies. Apollo Ventures focuses on assets with the potential to treat, prevent, or even reverse age-related diseases such as Alzheimer's, Heart Disease, Sarcopenia, Frailty, and Cancer, with the ultimate goal of increasing healthy human lifespan. Apollo invests in early stage companies, works with scientists and entrepreneurs to create new ventures, and engages in hypothesis-driven company building.
Visit website: http://apollo.vc/
People at Apollo Health Ventures
Apollo Health Ventures News
Focal Biosciences launched by PSI and Apollo Health Ventures
Business Wire - 11-Oct-2022
Aims to treat age-related diseases using advanced cellular reprogramming technologiesRead more...
$2.5M seed financing round closed by Cleara Biotech-targets cellular senescence
Longevity Technology - 03-Oct-2022
Cleara’s novel FOXO4-based treatment approach-ability to eliminate biomarker-positive scarred cellsRead more...
$100M fund - Life Extension Ventures might back startups working on longevity
TechCrunch - 18-Sep-2022
Founders are excited to find the impact when software intersects scienceRead more...
Apollo Health Ventures raised $180M fund to invest in longevity innovations
Endpoints News - 01-Dec-2021
Invests in early stage companies that target root causes of age-related diseasesRead more...
LEAF interviews Dr. Ole Mensching about Apollo Health Ventures' Moonshot Venture
Lifespan.io (LEAF) - 06-May-2020
VCs are starting to recognise ageing as a problem with a massive business opportunityRead more...
Samsara secures more funding for cellular rejuvenation drug research
Lifespan.io (LEAF) - 06-Mar-2019
Drugs will need to work better than the free alternative - calorie restrictionRead more...
Cleara Biotech Joins the Race to Develop Senolytic Therapies
Lifespan.io (LEAF) - 09-Jul-2018
This therapy uses a modified FOXO4 to promote apoptosis in senescent cellsRead more...